表紙:マルチプレックスアッセイの世界市場:製品、タイプ、テクノロジー、アプリケーション(研究開発、臨床診断)、エンドユーザー、地域別、予測と機会(2026年)
市場調査レポート
商品コード
1033260

マルチプレックスアッセイの世界市場:製品、タイプ、テクノロジー、アプリケーション(研究開発、臨床診断)、エンドユーザー、地域別、予測と機会(2026年)

Global Multiplex Assays Market, By Product, By Type, By Technology, By Application (Research & Development, Clinical Diagnosis, By End User, By Region, forecast & opportunities, 2026

出版日: | 発行: TechSci Research | ページ情報: 英文 114 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

マルチプレックスアッセイの世界市場:製品、タイプ、テクノロジー、アプリケーション(研究開発、臨床診断)、エンドユーザー、地域別、予測と機会(2026年)
出版日: 2021年10月01日
発行: TechSci Research
ページ情報: 英文 114 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のマルチプレックスアッセイ市場は、医療分野における技術の進歩、特にナノテクノロジーの急速な発展により、予測期間中に大幅な成長が見込まれています。

また、マルチプレックスアッセイが使用されているがんを含む慢性疾患の増加も、同市場の成長の主な要因となっています。シングルプレックスやその他の従来型診断法と比較して、マルチプレックス法には様々な利点があり、今後の同市場の成長を促進すると予想されています。

地域別では、北米が2026年までに世界市場の大半を占めると予想されており、先進的な医療システムと訓練を受けた専門家の存在に起因しています。また、同地域の各国政府は、診断のための先進技術の開発を支援しており、これがマルチプレックスアッセイの企業に大きな刺激を与えています。

当レポートは、世界のマルチプレックスアッセイ市場について調査しており、市場規模や予測、シェア、COVID-19の影響、成長要因や課題、製品・テクノロジー・アプリケーション・エンドユーザー・企業・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 世界のマルチプレックスアッセイ市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 顧客の声

第6章 世界のマルチプレックスアッセイ市場の見通し

  • 市場規模と予測
    • 売上別
  • 市場シェアと予測
    • 製品別(試薬と消耗品、アクセサリーと機器、ソフトウェアとサービス)
    • タイプ別(核酸、タンパク質、細胞ベース)
    • テクノロジー別(フローサイトメトリー、蛍光検出、発光、マルチプレックスリアルタイムPCR、その他)
    • アプリケーション別(研究開発、臨床診断)
    • エンドユーザー別(製薬・バイオテクノロジー企業、病院・研究、リファレンスラボ、その他)
    • 企業別(2021年)
    • 地域別
  • 製品市場マップ

第7章 アジア太平洋のマルチプレックスアッセイ市場の見通し

  • 市場規模と予測
    • 売上別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • テクノロジー別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • アジア太平洋:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第8章 欧州マルチプレックスアッセイ市場の見通し

  • 市場規模と予測
    • 売上別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • テクノロジー別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 北米マルチプレックスアッセイ市場の見通し

  • 市場規模と予測
    • 売上別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • テクノロジー別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第10章 南米のマルチプレックスアッセイ市場の見通し

  • 市場規模と予測
    • 売上別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • テクノロジー別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • コロンビア

第11章 中東およびアフリカのマルチプレックスアッセイ市場の見通し

  • 市場規模と予測
    • 売上別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • テクノロジー別
    • アプリケーション別
    • エンドユーザー別
    • 国別
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と発展

第14章 競合情勢

  • 競合の見通し
  • 企業プロファイル
    • Abbott Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers AG
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • BUHLMANN Laboratories AG
    • Sekisui Medical Co., Ltd.
    • Randox Laboratories Ltd.

第15章 戦略的提言

第16章 当社について&免責事項

目次
Product Code: 5055

Global multiplex assays market is expected to undergo substantial rate of growth during the forecast period owing to technological advancements in healthcare sector, especially rapid development in nano technology. Increasing prevalence of chronic diseases including cancer, where multiplex assays are significantly used, is also a major driving factor for the growth of this market. Additionally, various benefits of multiplex assays over singleplex and other traditional diagnostics is also anticipated to fuel the growth of multiplex market in the years to come.

Multiplex assay is a type of assay which measures multiple analytes in a single cycle. They are widely used in functional genomics to determine the effects of experimental treatments. A multiplex assay detects proteins and other biomolecules in a biological sample.

Global multiplex assays market can be segmented based on product, type, technology, application, end user and region. Based on technology, the market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR and others. The flow cytometry segment is expected to undergo significant growth during the forecast period as it works on the basis of bead population, which is helpful in computing specific antibody levels in biological fluids.

Region wise, North America is expected to dominate the global multiplex assays market by 2026 owing to regions' advanced healthcare system and availability of trained professionals. Various governments in the region are also supporting the development of advanced technologies for diagnostics, which is giving a major boost to multiplex assay companies.

Major companies operating in global multiplex assays market include Thermo Fisher Scientific Inc, Luminex Corporation, Illumina Inc, Qiagen N.V., Bio Rad Laboratories Inc, Abcam Plc, Agilent Technologies, Merck Sharp & Dohme Corp, Randox Laboratories Ltd, Meso Scale Diagnostics LLC, Seegene Inc., Becton, Dickinson and Company, Quansys Biosciences, Olink, Bio-Techne, Johnson & Johnson Services, Inc. and Hoffmann-La Roche Ltd, among others. Prominent market players are extensively undergoing research and development activities in order to introduce superior quality assays in the market.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze and forecast the market size of global multiplex assays market.
  • To forecast global multiplex assays market based on product, type, technology, application, end user, company and regional distribution.
  • To identify drivers and challenges for global multiplex assays market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global multiplex assays market.
  • To identify and analyze the profile of leading players operating in the global multiplex assays market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of multiplex assays manufacturing companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global multiplex assays market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Multiplex assays manufacturers, vendors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to multiplex assays
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as multiplex assays manufacturing companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global multiplex assays market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Multiplex Assays Market, By Product:

Reagents & Consumables

Accessories & Instruments

Software & Services

  • Global Multiplex Assays Market, By Type:

Nucleic Acid

Protein

Cell-based

  • Global Multiplex Assays Market, By Technology:

Flow Cytometry

Fluorescence Detection

Luminescence

Multiplex Real-Time PCR

Others

  • Global Multiplex Assays Market, By Application:

Research & Development

  • Drug Development
  • Biomarker Discovery & Validation

Clinical Diagnosis

  • Infectious Disease
  • Cancer
  • Cardiovascular Disease
  • Autoimmune Disease
  • Nervous System Disorders
  • Others
  • Global Multiplex Assays Market, By End User:

Pharmaceutical & Biotechnology Companies

Hospitals & Research Institutes

Reference Laboratories

Others

  • Global Multiplex Assays Market, By Region:

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global multiplex assays market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Multiplex Assays Market

4. Executive Summary

5. Voice of Customer

6. Global Multiplex Assays Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 6.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 6.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 6.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 6.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 6.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 6.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 6.2.6. By Company (2021)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Multiplex Assays Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 7.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 7.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 7.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 7.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 7.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 7.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 7.2.6. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Multiplex Assays Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. India Multiplex Assays Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Japan Multiplex Assays Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. South Korea Multiplex Assays Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Australia Multiplex Assays Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Europe Multiplex Assays Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 8.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 8.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 8.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 8.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 8.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 8.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Multiplex Assays Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Multiplex Assays Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Multiplex Assays Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Multiplex Assays Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Multiplex Assays Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. North America Multiplex Assays Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 9.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 9.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 9.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 9.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 9.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 9.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 9.2.6. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Multiplex Assays Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Mexico Multiplex Assays Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Canada Multiplex Assays Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. South America Multiplex Assays Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 10.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 10.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 10.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 10.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 10.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 10.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Multiplex Assays Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Multiplex Assays Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User

11. Middle East and Africa Multiplex Assays Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 11.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 11.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 11.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 11.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 11.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 11.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Multiplex Assays Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Type
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Multiplex Assays Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Type
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Multiplex Assays Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Type
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Abbott Laboratories, Inc.
    • 14.2.2. Thermo Fisher Scientific, Inc.
    • 14.2.3. Danaher Corporation
    • 14.2.4. F. Hoffmann-La Roche AG
    • 14.2.5. Siemens Healthineers AG
    • 14.2.6. Bio-Rad Laboratories, Inc.
    • 14.2.7. bioMerieux SA
    • 14.2.8. BUHLMANN Laboratories AG
    • 14.2.9. Sekisui Medical Co., Ltd.
    • 14.2.10. Randox Laboratories Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer